About us

Scientists first. Consultants by design.

Agile Biomedical Consultants was founded by cancer researchers who took a new treatment from in vitro testing to Phase Ib clinical trials.

Our story

From the lab bench to partners in the UK and China

Since its founding, Agile Biomedical Consultants has grown to include experts from very different fields: DNA repair and cancer therapeutics, bioinformatics and data science, statistics, epidemiology and population health.

We work with companies, universities, public bodies and charities. Our international work now includes an operation in Hangzhou, China, where we are building a biopharmaceutical R&D service platform.

Our mission is to help organisations reach their goals at lower cost and with less friction, through flexibility, transparency and long-term partnership.

How we work

What you can expect from us

These principles shape every project and relationship.

Transparency

Clear, open communication at every stage, so you can make decisions with confidence.

Honesty

We report what the evidence shows, not what you might want to hear.

Rigour

Robust methods and cross-disciplinary review behind every result and recommendation.

Flexibility

Small senior teams that adapt to your project, timeline and budget.

Confidentiality

We are happy to sign NDAs, and protect your data and intellectual property.

Sustainability

Responsible practice, from sourcing to reducing waste and unnecessary travel.

Our team

The people behind Agile Biomedical

Directors and consultants with senior roles at leading UK universities.

Directors

Dr Hussein Al-Ali

Dr Hussein Al-Ali

Director
Senior Lecturer, Anglia Ruskin University, Cambridge

Hussein is a cancer biologist working between academic research and industry. His research focuses on detecting circulating tumour cells and on antibody-based cancer therapeutics, taking new treatments from early laboratory testing towards the clinic.

  • PhD from Brunel University London, on DNA damage detection and cancer therapy response
  • Long-standing translational collaborations with biotech partners, including Medannex (anti-annexin-A1 antibody MDX-124) and aTen Therapeutics
  • Developed imaging flow cytometry methods for sensitive detection of DNA damage
  • Led the company's Cambridge UK Biopharmaceutical R&D Service Platform, approved under Hangzhou's Dinghu talent programme in 2025
  • Vice-Chancellor's Awards for research impact and industry engagement
  • Circulating tumour cells
  • Therapeutic antibodies
  • Imaging flow cytometry
  • UK–China partnerships

4 publications

Prof Chris Parris

Prof Chris Parris

Director
Professor and Head of the School of Life Sciences, Anglia Ruskin University

Chris has spent four decades researching DNA repair and how it shapes the response of cancer patients to chemotherapy and radiotherapy. He combines deep expertise in cell and molecular biology with long experience of commercially sponsored research.

  • Head of the School of Life Sciences at Anglia Ruskin University since 2017, and Honorary Professor in Experimental Cancer Therapeutics at Brunel University London
  • Postdoctoral research at the US National Cancer Institute and Lawrence Livermore National Laboratory
  • Associate Editor of Oncogene (2022–2025)
  • Principal investigator on industry-sponsored and Innovate UK projects with partners including Medannex and aTen Therapeutics
  • Grant reviewer for the MRC, BBSRC and Breast Cancer Now
  • DNA repair
  • Cancer therapeutics
  • Radiation and chemotherapy response
  • Commercial research

57 publications

Consultants

Dr Shabina Hayat

Consultant, population health and cognitive ageing
Visiting Researcher, UCL and University of Cambridge

Shabina is an epidemiologist specialising in cognitive ageing and dementia, with more than twenty years of experience designing, running and quality-assuring large population cohort studies in the UK and internationally.

  • PhD in epidemiology from the University of Cambridge, on cognitive function in the EPIC-Norfolk cohort of more than 25,000 people
  • Managed fieldwork for the EPIC-Norfolk study for sixteen years, including introducing its cognitive assessments
  • Led fieldwork for the second wave of the Healthy Cognitive Ageing Project in the English Longitudinal Study of Ageing
  • Principal investigator on a US National Institute on Aging study of the Harmonised Cognitive Assessment Protocol
  • Over 80 peer-reviewed publications
  • Cohort studies
  • Cognitive ageing and dementia
  • Data linkage and governance
  • Fieldwork quality

90 publications

Dr Sarah Assaad

Consultant, epidemiology and statistics
Lecturer in Epidemiology and Statistics, UCL

Sarah is an epidemiologist and statistician working on cognitive ageing, dementia, care needs and health service use in older age, with research experience in the UK, Lebanon and South Korea.

  • PhD in Public Health and Primary Care from the University of Cambridge (Cambridge Trust scholar)
  • MPH in Epidemiology and Biostatistics from the American University of Beirut
  • Research Fellow on the ELSA-HCAP study at UCL, and module lead for practical statistics in mental health research
  • Coordinated the first dementia cohort study in Lebanon
  • Co-led NIH- and British Council-funded work on harmonising cognitive data, including a UK–South Korea collaboration
  • Epidemiology
  • Biostatistics
  • Ageing and dementia
  • Teaching

21 publications

Dr Timothy Hearn

Consultant, bioinformatics and data science
Senior Lecturer in Bioinformatics, Anglia Ruskin University; Affiliated Associate Professor, University of Cambridge

Tim is a bioinformatician and geneticist whose work spans genomic medicine, chronobiology and data science, from rare-disease genomics in the 100,000 Genomes Project to open-source analysis software.

  • PhD from the University of Cambridge, awarded the HE Woodman prize for the best thesis in biochemistry or genetics
  • Affiliated Associate Professor in the Department of Medical Genetics, University of Cambridge
  • Leads bioinformatics and data science degree programmes at Anglia Ruskin University
  • Principal investigator on projects funded by Gates Cambridge and the British Council
  • Fellow of the Royal Society of Biology and the Royal Society of Medicine
  • Genomic medicine
  • Analysis pipelines
  • Chronobiology
  • Data science

47 publications

Tell us about your project

Your first consultation is free. We will propose an approach, a timeline and costs tailored to your goals.

Start a conversation